Medicared For All Logo

Mamta Vijayvargiya in Kissimmee, Florida

Home Florida Kissimmee

Mamta Vijayvargiya has Hematology/oncology as her primary medical specialty. Their primary office is: 737 W Oak St in Kissimmee, Florida.

They're a part of the: Osceola Cancer Center medical group which has around 6 members. You can call their office at 407-933-2775 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1988 (around 36 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mamta Vijayvargiya Office Phone and Directions

Mamta Vijayvargiya
Osceola Cancer Center
737 W Oak St
Kissimmee, Florida 34741
407-933-2775


Patient Ratings
Please rate your experience with Mamta Vijayvargiya below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 407-933-2775


Enter a starting address:


Healthcare Info for Mamta Vijayvargiya

Medical School: Sorry, her university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Mamta Vijayvargiya is listed as: Hematology/oncology
Approximate Years of Experience: 36
PAC (PECOS ID)#: 7911033204
NPI #: 1598733685
NPI Created On: 03/14/2006
NPI Last Updated Listed as: 12/01/2009
Primary Taxonomy Code: 207RH0003X
License Number:
ME83720
Listed Gender: Female

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Hindi.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Complete blood cell count (red cells, white blood cell, platelets), automated test
  3. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  4. Irrigation of implanted venous access drug delivery device
  5. New patient office or other outpatient visit, typically 45 minutes
  6. Established patient office or other outpatient visit, typically 15 minutes
  7. Established patient office or other outpatient, visit typically 25 minutes
  8. Initial hospital inpatient care, typically 70 minutes per day
  9. Subsequent hospital inpatient care, typically 35 minutes per day
  10. Injection, dexamethasone sodium phosphate, 1 mg
  11. Injection, diphenhydramine hcl, up to 50 mg
  12. Injection, heparin sodium, per 1000 units

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788449743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $120

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788449747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818633207

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CYRAMZA

Open Associated Drug #1: 0002-7669-01

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: VERZENIO

Associated Drug #2: 0002-6216-54

Drug or Biological #3:: Drug

Product Category #3: Oncology

Name of Drug: RETEVMO

Name Of Drug #3: 0002-2980-60


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801971976

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802154727

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802177973

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802866281

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $100

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 802981235

Being Disputed:: No

Product Related: No


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832176577

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832176651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Hematology/oncology Professionals in Kissimmee

737 W Oak St
Kissimmee, FL
Osceola Cancer Center

1300 W Oak St
Kissimmee, FL
Florida Hospital Medical Group Inc

801 W Oak St
Kissimmee, FL
Florida Cancer Specialists And Research Institute, Llc

801 W Oak St
Kissimmee, FL
Florida Cancer Specialists And Research Institute, Llc

1300 W Oak St
Kissimmee, FL
Florida Hospital Medical Group Inc

400 Celebration Pl
Kissimmee, FL
Florida Hospital Medical Group Inc

Providers in Osceola Cancer Center

1.Rumpa Amornmarn

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Radiation Oncology

2.Roger Febres

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Hematology/oncology

3.Daniel Halili

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Radiation Oncology

4.Jorge Otoya

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Medical Oncology

5.Raul Vera-gimon

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Medical Oncology

6.Mamta Vijayvargiya

737 W Oak St
Kissimmee Fl 34741-4937
Osceola Cancer Center
Hematology/oncology

View all 6 members of Osceola Cancer Center medical group